AMARIN CORPORATION PLC

Consensus Amarin Corporation plc

Stocks

AMRN

US0231114044

Biotechnology & Medical Research

Delayed Nasdaq Other stock markets 02:04:33 08/08/2026 HKT			5-day change	1st Jan Change
14.32 ^USD	+0.39%		+0.39%	+2.58%

07-30	Amarin Corporation plc, Q2 2026 Earnings Call, Jul 29, 2026
07-30	Tranche Update on Amarin Corporation plc's Equity Buyback Plan announced on May 1, 2024.	CI

Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

28345a1b998b64c6b8b3c2a42.OOGx9UtXaokbYVlN9G8e7xvHjy632a3zBNZue8WIWCY.boiBhDo-KNxCEGsZhgNW3UOQ7EHb4PKKfeEBMrS-IXEVj9PDIAhY6EsRYQ~8c0357c2f7b7791dcc6790e483a09640

Analysts' recommendations: Amarin Corporation plc

27/10/25	Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit	RE
25/06/25	RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal	MT
25/10/23	Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3	MT
19/07/23	Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating	MT
06/01/23	Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30	MT
20/10/22	SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating	MT
06/05/22	JPMorgan Downgrades Amarin to Underweight From Neutral	MT
05/05/22	HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10	MT
05/05/22	SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10	MT
05/05/22	Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9	MT
17/02/22	SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating	MT
01/02/22	SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating	MT
12/05/21	AMARIN : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6	MT
02/02/21	AMARIN : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating	MT
23/12/20	AMARIN : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating	MT
08/12/20	AMARIN : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	AMARIN CORPORATION PLC			-	-	-15.85%
	WUXI APPTEC CO., LTD.					+22.58%
	ARGENX SE					+19.46%
	BIONTECH SE					+32.23%
	INSMED INCORPORATED					+48.97%
	WUXI BIOLOGICS (CAYMAN) INC.					+14.04%
	GENMAB A/S					+27.44%
	PHARMAESSENTIA CORPORATION					-16.8%
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.					+11.64%
	EXELIXIS, INC.					+0.81%
	Average					+14.45%
	Weighted average by Cap.					+20.99%

See all sector consensus

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

SELL

Number of Analysts

1

Last Close Price

14.26USD

Average target price

12.00USD

Spread / Average Target

-15.85%

High Price Target

12.00USD

Spread / Highest target

-15.85%

Low Price Target

12.00USD

Spread / Lowest Target

-15.85%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Jefferies & Co.
Northland Securities
SVB Securities LLC
JPMorgan Chase
SVB Leerink
HC Wainwright
Goldman Sachs

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

SELL

Number of Analysts

1

Last Close Price

14.26USD

Average target price

12.00USD

Spread / Average Target

-15.85%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
AMRN Stock
Consensus Amarin Corporation plc

The best tools reserved for subscribers to boost the performance of your investments!